The phosphorylation of the cyclic (c)AMP responsive element binding protein (CREB), a player in HER2-mediated cancer development41, was also lower in xenografts of mice treated with TDM1/lovastatin when compared with TDM1 alone (Fig. 4c, Supplementary Fig. 13F). Here, CREB1 is linked to cancer.